Sank A, Wei D, Reid J, Ertl D, Nimni M, Weaver F, Yellin A, Tuan T L
Department of Surgery, University of Southern California School of Medicine, Los Angeles 90033.
J Surg Res. 1994 Dec;57(6):647-53. doi: 10.1006/jsre.1994.1195.
Diabetic vascular disease is characterized pathologically by endothelial cell (EC) hyperplasia and basement membrane (BM) thickening. One key question regarding the pathogenesis of diabetic vascular disease is whether the EC or BM or both are primarily defective and responsible for these pathological changes. Previous studies, which took the approach of creating artificial diabetic conditions, have been inconclusive. It is known, however, that the extracellular matrix may be altered by glycosylation as a result of hyperglycemia, thereby altering EC function. To begin to address this question and more closely mimic the situation in vivo, we characterized human diabetic EC harvested from insulin-dependent diabetic mothers (IDDM) at the cellular and molecular levels. Human EC were isolated from both normal and IDDM umbilical cords and cellular functions evaluated using standard assays of attachment (% attached cells), proliferation (cpm/cell), resistance to detachment under shear stress (number of cells remaining attached), and glucose uptake (cpm/2 X 10(4) cells). Gene expression of major BM components (collagen type IV, laminin beta 1, and laminin beta 2) was quantified by Northern analysis. Diabetic EC demonstrated increased proliferation (two- to eightfold compared to normals), were 20-40% less resistant to shear stress and took up glucose 10-15% more slowly than normal EC. Furthermore, Northern analysis showed that the expression of major BM components was increased by an average of 10-18% in diabetic cells compared to normal cells. These results were consistent with in vivo observations and previously published data.(ABSTRACT TRUNCATED AT 250 WORDS)
糖尿病血管疾病的病理特征是内皮细胞(EC)增生和基底膜(BM)增厚。关于糖尿病血管疾病发病机制的一个关键问题是,EC还是BM或者两者均存在原发性缺陷并导致了这些病理变化。以往通过制造人工糖尿病条件进行研究的结果尚无定论。然而,已知高血糖会导致细胞外基质发生糖基化改变,进而影响EC功能。为了开始解决这个问题并更接近地模拟体内情况,我们在细胞和分子水平上对从胰岛素依赖型糖尿病母亲(IDDM)获取的人糖尿病EC进行了特征分析。从正常和IDDM脐带中分离出人EC,并使用附着(附着细胞百分比)、增殖(cpm/细胞)、剪切应力下抗脱离能力(剩余附着细胞数量)和葡萄糖摄取(cpm/2×10⁴细胞)的标准检测方法评估细胞功能。通过Northern分析对主要BM成分(IV型胶原、层粘连蛋白β1和层粘连蛋白β2)的基因表达进行定量。糖尿病EC表现出增殖增加(与正常细胞相比增加了2至8倍),对剪切应力的抵抗力降低20 - 40%,葡萄糖摄取比正常EC慢10 - (此处原文似乎有误,推测应为15%)。此外,Northern分析表明,与正常细胞相比,糖尿病细胞中主要BM成分的表达平均增加了10 - 18%。这些结果与体内观察结果和先前发表的数据一致。(摘要截断于250字)